HB 3934 creates two new "extended care permits" for dental hygienists in Oklahoma to expand access to preventive dental care for underserved populations. Permit I allows hygienists to provide services in schools, foster care, youth programs, and clinics for children (birth to grade 12) with specific experience requirements (1,200 hours or teaching). Permit II allows similar services for seniors (65+) and people with developmental disabilities in residential facilities, requiring 1,600 hours and special training. Both permits require supervision by a licensed dentist, restrict services to preventive care (like cleanings and fluoride), and mandate reporting to the supervising dentist. The bill directly affects dental hygienists seeking expanded practice and the vulnerable groups they serve in community settings.
SB 1447 prohibits the Oklahoma Employees Insurance Plan from awarding contracts to pharmacy benefits managers (PBMs) that have settled lawsuits, been fined, or faced judgments exceeding $4 million in the past five years. The bill requires that state contract evaluations must favor PBMs headquartered in Oklahoma for at least one year and disfavor PBMs with corporate ties to health insurers, retail pharmacies, specialty pharmacies, mail-order pharmacies, or drug manufacturers. Contracted PBMs must also certify compliance with Oklahoma’s health information laws and maintain SOC 2 Type 2 security certification. The law takes effect November 1, 2026.
SB 1567 modifies Oklahoma's rules for Advanced Practice Registered Nurses (APRNs) by allowing supervising physicians to charge reasonable fees for oversight services, requiring these fees to be disclosed in written agreements and based on fair market value. The bill prohibits the Oklahoma Board of Nursing from imposing fees for maintaining supervision agreements or related administrative tasks. It also mandates that supervision agreements include specific details like fee structures, scope of practice, emergency plans, and alternate physician designations. This directly affects APRNs who rely on physician supervision and supervising physicians, streamlining oversight requirements while ensuring transparency in fee arrangements.
SB 1500 requires pharmacy benefits managers (PBMs) and other payors to pay pharmacies within 30 days for "clean claims" (properly submitted claims without issues). It prohibits PBMs from conditioning payments on post-transaction reconciliations or shifting payment delays to pharmacies, and mandates transparent accounting for payments. The bill also authorizes Oklahoma’s Attorney General to impose fines for violations and voids contracts that violate these rules. These changes directly affect pharmacies (as providers) and PBMs/insurers (as payors) by standardizing payment timelines and reducing financial risk for pharmacies.
SB 1644 would require Oklahoma's health department to add alpha-gal syndrome (AGS) to the official list of reportable diseases, meaning doctors, nurses, and clinical laboratories must report diagnosed cases to the state health department. AGS is a condition causing allergic reactions to red meat and other animal products, which currently lacks formal tracking in Oklahoma. The bill updates existing health reporting laws to include AGS and makes the language gender-neutral. It would take effect on November 1, 2026.
SB 1255 requires Oklahoma's Department of Corrections medical director to certify qualifying medical conditions and request the Pardon and Parole Board to place eligible inmates on a special docket for compassionate parole consideration. It directly affects inmates with specific terminal or debilitating conditions like dementia, cancer, HIV/AIDS, or conditions causing near-death (six-month life expectancy), or those unable to perform basic self-care. The bill bypasses the standard two-step parole hearing process for these inmates and mandates that at least three Board members must concur to consider medical parole. The Board must document concurrence in meeting minutes, and parolees may face revocation if their medical condition poses public safety risks.
This bill proposes a constitutional amendment to expand Oklahoma's Medicaid program to cover low-income adults. It would require the state to maintain eligibility without additional restrictions and allow Oklahoma to halt Medicaid expansion funding if federal matching falls below 90%. The amendment must be approved by voters via ballot measure. If passed, it would change Medicaid eligibility rules and create a specific funding threshold for state coverage. The resolution directs the Secretary of State to place this proposal on the ballot for voter approval.
This bill requires Oklahoma hospitals to provide patients experiencing fetal death or miscarriage with a form explaining how to request official certificates (fetal death or stillbirth birth certificates) before discharge. Hospitals must also verbally inform patients about these certificate options. The State Department of Health must create and publish this standardized form online, including clear instructions and contact details for vital records. The law takes effect November 1, 2026, directly affecting hospitals and patients in Oklahoma facing these medical circumstances.
SB 1645 establishes new rules for auditing long-term care providers (like nursing homes and Medicaid home-care agencies) under Oklahoma's Medicaid program. It requires the Oklahoma Health Care Authority to give providers 1 week's notice before audits, limits audits to 50 claims or 0.25% of annual claims, and prohibits holding providers liable for simple clerical errors (like typos) as fraud. Providers must be allowed 60 days to correct claims after an audit, and recoupments (recovery of overpaid funds) can only apply to corrected claims, not original billing errors. The bill also creates a two-step appeals process, allowing providers to challenge audit results through the Authority and then to an administrative law judge.
SB 2007 requires pharmacy benefit managers (PBMs) in Oklahoma to pay administrative fees to pharmacies when they adjust reimbursement rates for the same drug within 30 days after a successful appeal. Specifically, if a PBM increases reimbursement based on an appeal but then lowers it again for the same drug within 30 days, the PBM must pay $100 immediately, escalating to $500 after 90 days or $1,000 after 180 days if unpaid. The bill directly affects pharmacies and PBMs by mandating these fee payments for disputed reimbursements, ensuring providers aren’t financially penalized for legitimate appeal outcomes. It also includes other provisions like weekly MAC price updates and requirements for PBMs to provide clear documentation during reimbursement disputes. The law takes effect November 1, 2026.
